When Fatty Liver Disease Leads to Liver Transplantation

NASH (Non-Alcoholic Steatohepatitis), now more commonly referred to as MASH (Metabolic Dysfunction-Associated Steatohepatitis), is a severe form of fatty liver disease. It can silently progress to fibrosis, cirrhosis, liver failure, and ultimately the need for a liver transplant.
📈 Today, MASH has become one of the leading causes of liver transplantation in many countries, and its burden continues to rise alongside increasing rates of obesity, diabetes, and physical inactivity.

👶 What About Children?

This disease is no longer limited to adults.
🔹 MASLD/MASH is now one of the most common chronic liver diseases affecting children in many parts of the world.
🔹 A recent global meta-analysis estimates that 7% of children and young people aged 5–24 years are living with MASLD, with significantly higher rates among those affected by obesity.
🔹 Experts from the Journal of Hepatology estimate that the global pediatric prevalence could reach 7.5%, with a continued increase across all regions of the world.

✅ The Good News: Prevention Works
Most cases can be prevented or slowed through:
✔️ A healthy, balanced diet
✔️ Regular physical activity
✔️ Maintaining a healthy weight
✔️ Preventing and managing diabetes
✔️ Reducing consumption of ultra-processed foods and sugary beverages
✔️ Early screening for people at risk

📚 Scientific References

1. Stroes et al. Pediatric MASLD: Current Understanding and Practical Approach. European Journal of Pediatrics, 2024.
2. Liu et al. Global and Regional Prevalence, Burden and Risk Factors for MASLD in Children and Adolescents: Systematic Review and Meta-analysis. BMC Medicine, 2026.
3. Updates in Clinical Medicine: MASLD in Children and Adolescents. Journal of Hepatology, 2026.
🧡 Act Now. Screen Early. Protect Your Liver.
Protecting children's liver health today means preventing liver transplantation tomorrow.